Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Expert Opinion on Therapeutic Targets|July 7, 2007
Immunomodulating role of bisphosphonates on human gamma delta T cells: an intriguing and promising aspect of their antitumour activityS Galluzzo, D Santini, B Vincenzi, et al.
Thrombosis and Haemostasis|December 17, 1985
Anticoagulant activity in cell-free peritoneal fluid of an experimental pancreatic ascites tumorC Ts'ao, T S Galluzzo, S J Hart, et al.
Clinical and Experimental Rheumatology|July 28, 2006
The adjunctive role of antiphospholipid antibodies in systemic lupus erythematosus cardiac involvementA Amoroso, F Cacciapaglia, S De Castro, et al.
Current Cancer Drug Targets|December 23, 2009
Denosumab: the era of targeted therapies in bone metastatic diseasesD Santini, M E Fratto, B Vincenzi, et al.
Annals of the Rheumatic Diseases|September 16, 2003
Raynaud's phenomenon and antiphospholipid antibodies in systemic lupus erythematosus: is there an association?D Caccavo, F Del Porto, P Garzia, et al.
Clinical and Experimental Immunology|October 2, 2008
Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypesD Santini, S Angeletti, A Ruzzo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 2010
Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patientsB Vincenzi, S Galluzzo, D Santini, et al.
Cancer Treatment Reviews|December 7, 2010
New molecular targets in bone metastasesD Santini, S Galluzzo, A Zoccoli, et al.
La Clinica Terapeutica|July 6, 2000
[A 73-year-old woman with vomiting and metabolic alkalosis]A Picardi, S Manfrini, F Navajas, et al.
Pageof 3